Edwards Lifesciences (EW) Price to FCF (2009 - 2026)

Edwards Lifesciences has reported Price to FCF for 18 years, with the latest figure at 89.16 in Q2 2026.

• On a quarterly basis, Price to FCF fell 53.29% year-over-year to 89.16 in Q2 2026; TTM through Jun 2026 was 36.38, a 53.48% decrease from a year earlier, with the FY2025 full-year figure at 37.08, down 75.33% from the prior year.
• Price to FCF was 89.16 for Q2 2026 at Edwards Lifesciences, up from 2189.87 in the prior quarter.
• The five-year high for Price to FCF was 948.94 in Q4 2023, with the low at 4010.01 in Q2 2023.
• Average Price to FCF over 5 years is 205.07, with a median of 164.69 recorded in 2025.
• The largest YoY upside for Price to FCF was 347.23% in 2023 against a maximum downside of 2067.01% in 2023.
• Over 5 years, Price to FCF stood at 212.18 in 2022, then surged by 347.23% to 948.94 in 2023, then tumbled by 125.9% to 245.76 in 2024, then surged by 156.98% to 140.04 in 2025, then slumped by 36.33% to 89.16 in 2026.
• The last three Price to FCF figures came in at 89.16 (Q2 2026), 2189.87 (Q1 2026), and 140.04 (Q4 2025), per Business Quant data.